Study guide
21.1 MCV-Based Diagnostic Approach to Anaemia
MRCP UK
Track your progress as you read
Finished sections get a check mark.
1 MRCP(UK) Part 1: Exam Overview, Blueprint & Strategy
1.1 Part 1 Format, Delivery and Fees 1.2 The Official Blueprint and Mark Allocation 1.3 Scaled Scoring, Attempt Limits and Best-of-Five Technique
2 Clinical Sciences: Cellular, Genetic & Molecular Medicine
2.1 Organelles, Cytoskeleton & Membrane Transport 2.2 Cell Cycle Control, Apoptosis & Cell Signalling 2.3 Mendelian & Non-Mendelian Inheritance 2.4 Trinucleotide Repeat Disorders & Chromosomal Abnormalities 2.5 Purine, Pyrimidine Metabolism & the Porphyrias 2.6 Glycogen, Lipid Storage & Amino Acid Disorders
3 Clinical Sciences: Anatomy, Physiology & Immunology
3.1 Clinical & Cross-Sectional Anatomy 3.2 Systemic Clinical Physiology & Homeostasis 3.3 Clinical Immunology & Hypersensitivity Reactions
4 Clinical Sciences: Statistics, Epidemiology & Trial Design
4.1 Study Designs & Evidence Hierarchy 4.2 Diagnostic Testing, Screening & Predictive Values 4.3 Statistical Analysis & Risk Quantification
5 Clinical Pharmacology, Therapeutics & Toxicology
5.1 Pharmacokinetics & Pharmacodynamics 5.2 Cytochrome P450 Systems & High-Risk Drug Interactions 5.3 Adverse Drug Reactions & Therapeutic Drug Monitoring 5.4 Paracetamol & Salicylate Poisoning 5.5 Toxidromes, Antidotes, Carbon Monoxide & Toxic Alcohols
6 Cardiology: Coronary Artery Disease & Heart Failure
6.1 Acute Coronary Syndromes & Myocardial Infarction 6.2 Heart Failure & Cardiomyopathies 6.3 Cardiac Assessment & ECG Interpretation
7 Cardiology: Arrhythmias, Valvular & Pericardial Disease
7.1 Atrial Fibrillation, Narrow & Broad Complex Tachycardias 7.2 Bradyarrhythmias, Conduction Block & Antiarrhythmic Drugs 7.3 Valvular Heart Disease & Murmur Interpretation 7.4 Infective Endocarditis 7.5 Pericardial & Acute Aortic Diseases
8 Respiratory Medicine: Airway & Parenchymal Lung Disease
8.1 Asthma: Diagnosis, Chronic Management & Acute Attacks 8.2 COPD: GOLD Staging, Stable Management, Exacerbations & NIV 8.3 Interstitial Lung Disease & Sarcoidosis 8.4 Respiratory Infections & Bronchiectasis
9 Respiratory Medicine: Vascular, Pleural & Sleep Disorders
9.1 Venous Thromboembolism & Pulmonary Embolism 9.2 Pleural Effusion & Pneumothorax 9.3 Respiratory Failure & Sleep-Disordered Breathing
10 Gastroenterology: Luminal Gastrointestinal Disease
10.1 GORD, Barrett's Oesophagus & Oesophageal Motility Disorders 10.2 Peptic Ulcer Disease, Helicobacter pylori & Zollinger-Ellison Syndrome 10.3 Crohn's Disease, Ulcerative Colitis & Extraintestinal Manifestations 10.4 IBD Medical Therapy, Coeliac Disease & Malabsorption 10.5 Acute Upper Gastrointestinal Bleeding: Risk Scores, Ulcer & Variceal Haemorrhage 10.6 Lower Gastrointestinal Disorders & Colonic Neoplasia
11 Gastroenterology: Liver, Biliary & Pancreatic Disease
11.1 Viral Hepatitis A to E 11.2 Autoimmune Hepatitis & Metabolic Liver Disease 11.3 Cirrhosis & Complications of Portal Hypertension 11.4 Cholestatic Liver Disease: PBC and PSC 11.5 Gallstone Disease, Biliary Sepsis & Pancreatitis
12 Endocrinology & Diabetes: Diabetes & Thyroid
12.1 Diabetes: Diagnostic Thresholds, Classification & Pathophysiology 12.2 NICE-Directed Type 2 Therapy & Microvascular Complications 12.3 Acute Diabetic Emergencies (DKA & HHS) 12.4 Thyrotoxicosis, Thyroiditis & Management of Hyperthyroidism 12.5 Hypothyroidism, Subclinical Disease & Thyroid Nodules
13 Endocrinology & Diabetes: Adrenal, Pituitary & Calcium
13.1 Hypopituitarism, Pituitary Apoplexy & Hyperprolactinaemia 13.2 Acromegaly, Diabetes Insipidus & SIADH 13.3 Cushing's Syndrome: Aetiology, Screening & Localisation 13.4 Adrenal Insufficiency & Endocrine Hypertension 13.5 Calcium Regulation & Hypercalcaemia 13.6 Hypocalcaemia & Metabolic Bone Disease
14 Renal Medicine: AKI, Glomerular & Tubulointerstitial Disease
14.1 Acute Kidney Injury & Chronic Kidney Disease 14.2 Nephrotic and Nephritic Syndromes & Primary Glomerular Disease 14.3 Rapidly Progressive Glomerulonephritis 14.4 Tubulointerstitial & Inherited Renal Diseases
15 Renal Medicine: Fluid, Electrolytes & Acid-Base Balance
15.1 Sodium & Water Disorders 15.2 Potassium, Magnesium & Phosphate Disorders 15.3 Acid-Base Disorders & Blood Gas Analysis
16 Neurology: Cerebrovascular, Headache & Demyelinating Disease
16.1 Stroke Classification, Brainstem Syndromes & Hyperacute Reperfusion 16.2 Secondary Prevention, TIA, Carotid Surgery & Intracranial Haemorrhage 16.3 Headache Disorders & Cranial Neuralgias 16.4 Multiple Sclerosis & Central Demyelinating Diseases
17 Neurology: Epilepsy, Movement Disorders & Neuromuscular Disease
17.1 Epilepsy & Acute Seizures 17.2 Movement Disorders & Cognitive Impairment 17.3 Neuromuscular Junction & Peripheral Nerve Disorders
18 Rheumatology: Inflammatory Arthritis & Connective Tissue Disease
18.1 Rheumatoid Arthritis: Pathophysiology, Clinical Features & Diagnosis 18.2 DMARDs, Biologics & Their Toxicities 18.3 Seronegative Spondyloarthropathies 18.4 Systemic Lupus Erythematosus & Drug-Induced Lupus 18.5 Systemic Sclerosis & Scleroderma Renal Crisis 18.6 Sjogren's Syndrome & Inflammatory Myopathies
19 Rheumatology: Systemic Vasculitis & Crystal Arthropathy
19.1 Vasculitis Classification, Large and Medium Vessel Disease 19.2 ANCA-Associated and Immune Complex Small Vessel Vasculitis 19.3 Gout & Calcium Pyrophosphate Deposition Disease
20 Infectious Diseases & Tropical Medicine
20.1 Sepsis-3 Definitions & the Sepsis Six 20.2 Bacterial Meningitis, CSF Interpretation & Toxic Shock Syndrome 20.3 Tuberculosis: Pathogenesis & Clinical Manifestations 20.4 Tuberculosis: Diagnosis & Anti-Tuberculous Therapy 20.5 HIV Infection & Opportunistic Diseases 20.6 Malaria: Species, Life Cycle & Severe Disease 20.7 Enteric Fever, Arboviral Infection & Tissue Parasites
21 Haematology: Anaemias & Red Cell Disorders
21.1 MCV-Based Diagnostic Approach to Anaemia 21.2 Haemolytic and Autoimmune Haemolytic Anaemias 21.3 Membranopathies, Enzymopathies, PNH & Sickle Cell Disease
22 Haematology: Malignancy, Coagulation & Transfusion Medicine
22.1 Acute Leukaemias 22.2 Chronic Leukaemias & Myeloproliferative Neoplasms 22.3 Lymphomas & Plasma Cell Dyscrasias 22.4 Coagulation Cascade & Inherited Bleeding Disorders 22.5 Thrombocytopenia & Thrombotic Microangiopathies 22.6 Transfusion Products & Acute Transfusion Reactions
23 Psychiatry in General Medicine
23.1 Mood & Psychotic Disorders in Medical Patients 23.2 Psychiatric Emergencies & Substance Misuse 23.3 Mental Capacity & UK Mental Health Law
24 Geriatric Medicine
24.1 Comprehensive Geriatric Assessment, Frailty, Delirium & Falls 24.2 Polypharmacy, Deprescribing & Pressure Ulcers
25 Dermatology
25.1 Inflammatory Skin Disease, Immunobullous Disorders & Severe Drug Eruptions 25.2 Cutaneous Malignancy
26 Oncology & Palliative Medicine
26.1 Neutropenic Sepsis, Spinal Cord Compression & SVC Obstruction 26.2 Hypercalcaemia of Malignancy & Tumour Lysis Syndrome 26.3 Palliative Care & End-of-Life Symptom Control
27 Medical Ophthalmology
27.1 The Acute Red Eye & Sudden Painless Visual Loss 27.2 Retinopathy in Systemic Disease
21.1 MCV-Based Diagnostic Approach to Anaemia
Key Takeaways Explain This Topic AI
Ferritin is an acute phase reactant, so a normal ferritin does not exclude iron deficiency in inflammation; a low transferrin saturation with raised total iron-binding capacity supports it.
Beta-thalassaemia trait shows microcytosis disproportionate to the degree of anaemia with a raised HbA2 on electrophoresis and a normal or raised ferritin.
Hypersegmented neutrophils indicate megaloblastic anaemia; B12 must be replaced before folate to avoid precipitating subacute combined degeneration of the cord.
Last updated: September 2026
Anaemia is defined by the World Health Organization (WHO) as a haemoglobin concentration <130 g/L in adult men, <120 g/L in non-pregnant women, and <110 g/L in pregnant women. In the MRCP(UK) Part 1 examination, questions on anaemia demand rigorous algorithmic problem-solving based on the Mean Corpuscular Volume (MCV), precise biochemical differentiation of iron parameters, and deep pathophysiological knowledge of haemolytic conditions and globin chain mutations.
1. Algorithmic Diagnostic Approach Based on Mean Corpuscular Volume (MCV)
The initial diagnostic step in evaluating any anaemia is categorizing the red cell size via the MCV into microcytic (<80 fL), normocytic (80–100 fL), or macrocytic (>100 fL). Anaemia Workup Flowchart
- |
- +-------------------+-------------------+
- | |
- MCV < 80 fL MCV > 100 fL
- (Microcytic Anaemia) (Macrocytic Anaemia)
- | |
- +-----------+-----------+ +-----------+-----------+
- | | | | |
- Ferritin Ferritin Mentzer Blood Film Non-Megaloblastic
- < 30 ug/L Normal/High < 13 Hypersegmented (Alcohol, Liver,
- (IDA) (ACD) (Thalassaemia) Neutrophils MDS, Thyroid)
- |
- +---------+---------+
- | |
- Low Serum B12 Low Folate
- (Pernicious Anaemia) (Dietary/Malabsorption)
- A. Microcytic Anaemias (MCV <80 fL)
Microcytosis reflects impaired haemoglobin synthesis inside maturing erythroid precursors, stemming from deficient iron availability, defective globin chain production, or impaired protoporphyrin synthesis.
Iron Deficiency Anaemia (IDA):
Biochemical Profile: Serum ferritin <30 ug/L (the single most sensitive and specific biochemical test for total body iron depletion; levels <15 ug/L are definitively diagnostic), elevated Total Iron-Binding Capacity (TIBC / transferrin), low serum iron, and transferrin saturation <16%.
Important Diagnostic Caveat: Ferritin is an acute-phase reactant. In the presence of systemic inflammation, infection, chronic kidney disease, or hepatic necrosis, a ferritin value up to 100 ug/L may still be compatible with coexistent iron deficiency.
Clinical Investigation Mandate: In the UK (NICE and British Society of Gastroenterology guidelines), unexplained iron deficiency anaemia in all men and post-menopausal women requires urgent bidirectional endoscopy (oesophagogastroduodenoscopy [OGD] and colonoscopy) to exclude occult gastrointestinal malignancy (colorectal adenocarcinoma, gastric carcinoma), even in the complete absence of gastrointestinal symptoms. Coeliac serology (anti-tissue transglutaminase IgA and total IgA) must be checked in all patients.
Anaemia of Chronic Disease / Inflammation (ACD):
Pathophysiology: Driven by pro-inflammatory cytokines, predominantly interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-a). IL-6 stimulates hepatic production and secretion of hepcidin , the master iron-regulatory hormone. Hepcidin binds to and induces the internalization and lysosomal degradation of ferroportin-1 (the sole known cellular iron exporter on duodenal enterocytes and reticuloendothelial macrophages). This traps iron inside macrophages, prevents intestinal iron absorption, and starves erythroid precursors of iron despite abundant total body iron stores.
Biochemical Profile: Serum ferritin is normal or elevated (>100 ug/L), TIBC is low or normal, serum iron is low, and soluble transferrin receptor (sTfR) is normal (in contrast to IDA where sTfR is elevated).
Thalassaemias:
Characterized by intact iron stores but profound microcytosis disproportionate to the degree of anaemia (MCV often <70 fL with Hb 100–110 g/L).
Mentzer Index: Calculated as MCV / RBC count (in millions/uL). A Mentzer index <13 strongly points to a thalassaemia trait, whereas an index >13 points toward iron deficiency anaemia.
Beta-Thalassaemia Trait (Minor): Heterozygous point mutations in the HBB gene on chromosome 11. Hemoglobin electrophoresis or HPLC reveals characteristically elevated HbA2 >3.5% (typically 4.0–6.0%) and mildly elevated HbF (1–3%). Blood film shows target cells, basophilic stippling, and microcytic hypochromic red cells.
Alpha-Thalassaemia Trait: Gene deletions in the duplicated HBA1 and HBA2 globin genes on chromosome 16. Two-gene deletion (alpha-thalassaemia minor / trait: -a/-a or --/aa) presents with microcytosis but normal hemoglobin electrophoresis in adults (because alpha chains participate equally in HbA, HbA2, and HbF). Three-gene deletion (--/-a) results in HbH disease , producing unstable beta-globin tetramers (HbH) that precipitate as "golf-ball" inclusions on brilliant cresyl blue supravital staining, presenting with moderate-to-severe chronic haemolytic anaemia and splenomegaly. Four-gene deletion (--/--) produces Hb Barts (gamma-4 tetramers), causing fatal hydrops fetalis in utero.
Sideroblastic Anaemias:
Characterized by defective incorporation of iron into the protoporphyrin IX ring within erythroid mitochondria, resulting in pathological mitochondrial iron accumulation ringing the nucleus.
Diagnosis: Bone marrow aspirate stained with Prussian blue (Perls' stain) demonstrates >=5 ringed sideroblasts (erythroblasts containing >=5 siderotic granules encircling at least one-third of the nuclear circumference).
Aetiologies:
Hereditary: X-linked defect in delta-aminolevulinate synthase 2 (ALAS2) , the initial and rate-limiting enzyme in erythroid haem biosynthesis (responsive to pyridoxine / vitamin B6).
Acquired Clonal: Myelodysplastic neoplasms with ring sideroblasts (MDS-RS), strongly associated with somatic mutations in the RNA splicing gene SF3B1 .
Acquired Reversible: Chronic alcohol toxicity, lead poisoning (inhibits ALA dehydratase and ferrochelatase; coarse basophilic stippling on blood film), medications (isoniazid, which antagonizes pyridoxal phosphate; chloramphenicol), and severe copper deficiency (often secondary to zinc toxicity).
B. Normocytic Anaemias (MCV 80–100 fL)
The fundamental discriminator in normocytic anaemia is the reticulocyte count (or reticulocyte production index, RPI):
High Reticulocyte Response (>2.0% or >100 x 10^9/L):
Indicates appropriate bone marrow erythroid hyperplasia responding to acute peripheral erythrocyte loss or accelerated destruction.
Primary Causes: Active haemolysis (immune, enzymopathy, membranopathy, microangiopathy) or acute haemorrhage/blood loss.
Low or Inappropriate Reticulocyte Response (<2.0% or <50 x 10^9/L):
Indicates defective bone marrow production or systemic suppression of erythropoiesis.
Primary Causes:
Erythropoietin (EPO) Deficiency: Chronic kidney disease (CKD stage 3b–5; reduced peritubular interstitial fibroblastic EPO production).
Bone Marrow Failure: Aplastic anaemia (pancytopenia with hypocellular fatty marrow), pure red cell aplasia (PRCA; isolated erythroblastopenia, strongly associated with thymoma, Parvovirus B19, and ABO-incompatible allogeneic bone marrow transplantation), or myelophthisic marrow infiltration (metastatic carcinoma, haematological malignancy, granulomas).
Endocrine Hypofunction: Hypothyroidism, hypoadrenalism (Addison's disease), and hypogonadism.
C. Macrocytic Anaemias (MCV >100 fL)
Macrocytosis is divided pathophysiologically into megaloblastic and non-megaloblastic forms based on peripheral blood film morphology.
Megaloblastic Anaemias (Nuclear-Cytoplasmic Dyssynchrony):
Caused by impaired DNA synthesis with preserved RNA and protein synthesis, resulting in large, immature-appearing nuclei with fine, delicate chromatin in cells with mature, fully haemoglobinized cytoplasm.
Peripheral Blood Film Hallmark: Oval macrocytes and hypersegmented neutrophils (defined as the presence of >=5 nuclear lobes in >5% of neutrophils, or any single neutrophil with >=6 lobes). This is one of the most sensitive morphological markers of megaloblastosis.
Vitamin B12 (Cobalamin) vs Folate Deficiency:
Both deficiencies elevate plasma homocysteine levels (because both are required for methionine synthase activity).
Methylmalonic Acid (MMA): Elevated strictly in Vitamin B12 deficiency (cobalamin is a mandatory cofactor for methylmalonyl-CoA mutase, converting methylmalonyl-CoA to succinyl-CoA). MMA is completely normal in isolated folate deficiency , making serum MMA the definitive biochemical test when B12 levels are borderline.
Pernicious Anaemia: Autoimmune destruction of gastric parietal cells in the gastric body and fundus, leading to achlorhydria and loss of intrinsic factor (IF) secretion. Associated with HLA-DR3/DR4, autoimmune thyroid disease, and vitiligo. Diagnostic antibodies:
Anti-Intrinsic Factor Antibodies: Moderate sensitivity (~50-70%) but exceptionally high specificity (>95-98%) ; positive serology confirms pernicious anaemia.
Anti-Parietal Cell Antibodies: High sensitivity (~90%) but poor specificity (~50%), positive in atrophic gastritis and elderly controls.
Subacute Combined Degeneration of the Cord (SCD): Severe neurological complication exclusive to cobalamin deficiency. Defective myelin methylation leads to symmetrical demyelination of:
Dorsal (posterior) columns: Loss of vibration sense and proprioception, positive Romberg's sign, sensory ataxia.
Lateral corticospinal tracts: Upper motor neuron signs including spastic paraparesis, hyperreflexia, and extensor plantar responses (positive Babinski sign).
Peripheral nerves: Symmetrical sensory peripheral neuropathy with absent ankle reflexes (producing paradoxical combination of brisk knee jerks, extensor plantars, and absent ankle jerks).
CRITICAL EXAM WARNING: In a patient with megaloblastic anaemia or combined deficiency, folic acid must NEVER be administered without adequate Vitamin B12 replacement . Folic acid drives DNA synthesis and temporarily corrects the peripheral haematological indices while rapidly precipitating or irreversibly worsening catastrophic subacute combined degeneration of the spinal cord!
Non-Megaloblastic Macrocytosis:
Normal DNA synthesis without hypersegmented neutrophils. Red cells appear uniformly round rather than oval.
Common Causes: Chronic alcohol excess (direct bone marrow toxic effect; most common cause of non-anaemic macrocytosis), chronic liver disease (abnormal lipid deposition on erythrocyte membranes), marked reticulocytosis (reticulocytes are 20% larger than mature erythrocytes), hypothyroidism, myelodysplastic syndrome (MDS), and antimetabolite/cytotoxic drugs ( hydroxycarbamide , azathioprine , 6-mercaptopurine , and methotrexate).
2. Comparative Table: Comprehensive Workup of Anaemias by MCV
Classification Representative Conditions Diagnostic Serum Biomarkers Peripheral Blood Film Features Specific Confirmatory Testing
Microcytic (MCV <80 fL) Iron Deficiency Anaemia Ferritin <30 ug/L, Low Fe, High TIBC, Transferrin sat <16% Microcytic hypochromic cells, pencil cells, anisopoikilocytosis Bidirectional GI endoscopy (NICE: men and post-menopausal women)
Microcytic (MCV <80 fL) Anaemia of Chronic Disease Ferritin normal/elevated (>100 ug/L), Low Fe, Low/normal TIBC Normochromic or mildly hypochromic, normal morphology Normal soluble transferrin receptor; elevated CRP/ESR
Microcytic (MCV <80 fL) Beta-Thalassaemia Trait Normal iron and ferritin; Mentzer index (MCV/RBC) <13 Disproportionate microcytosis, target cells, basophilic stippling Haemoglobin electrophoresis / HPLC: HbA2 >3.5%
Microcytic (MCV <80 fL) Sideroblastic Anaemia Elevated serum iron and ferritin; Transferrin sat >50% Dimorphic red cell population (microcytic and normocytic) Bone marrow Prussian blue stain: >=5 ringed sideroblasts
Normocytic (MCV 80–100 fL) Haemolytic Anaemias Elevated reticulocytes (>2%), High unconjugated bilirubin, High LDH Spherocytes, schistocytes, bite cells, or polychromasia Depleted haptoglobin, Direct Antiglobulin Test (DAT / Coombs)
Normocytic (MCV 80–100 fL) Chronic Kidney Disease Low reticulocytes (<2%), elevated creatinine, low eGFR Normochromic normocytic cells; burr cells (echinocytes) in uraemia Inappropriately low serum erythropoietin (EPO) level
Macrocytic (MCV >100 fL) B12 / Folate Deficiency Low serum B12 or red cell folate; elevated homocysteine Oval macrocytes, hypersegmented neutrophils (>=5 lobes) Elevated methylmalonic acid (B12 only); Anti-IF antibodies
Macrocytic (MCV >100 fL) Alcohol / Liver Disease Normal B12/folate; elevated GGT, AST > ALT (2:1) Round macrocytes, target cells, stomatocytes Clinical history, liver ultrasound, resolution on abstinence